urokinase

In this process, urokinase - type plasminogen activator ( uPA ) and P - selectin play a very important role.

在此過程中, 尿激酶型纖溶酶原激活物(urokinase -type plasminogenactivator,uPA ) 和P - 選擇素起著十分重要的作用.

互聯網

Methods All 82 patients received intravenous urokinase ( UK ) for acute ischemic stroke.

方法　82例急性腦梗死患者接受尿激酶 ( UK ) 靜脈溶栓治療.

互聯網

D - dimer; lower extremity deep venous thrombosis; thrombolytic therapy; urokinase.

D - 二聚體; 下肢深靜脈血栓形成; 溶栓治療; 尿激酶.

互聯網

Subconjunctival injection urokinase combined with dexamethasone was performed 2 - 3 times.

藥物治療行尿激酶聯合地塞米松結膜下注射,共2~次.

互聯網

Methods: Non - glycosylated pro - urokinase was created by Asn 302 - Ala 302 mutagenesis.

方法: 將302位天冬酰胺(Asn302)突變為丙氨酸(Ala302 ),構建非糖基化尿激酶原.

互聯網

Objective To discuss the clinical effect on ventricular hemorrhage by lateral ventricular exporting and infusing Urokinase.

目的探討側腦室引流術及注入尿激酶治療腦室出血的臨床療效.

互聯網

Conclusions: Intravenous urokinase thrombolysis could an effective and safe treatment for acute cerebral infarction.

結論: 尿激酶靜脈溶栓治療急性腦梗死有效且相對安全.

互聯網

Objective: To identify of urokinase - type plasminogen activator ( UPA ) expression in patients with epithelial ovarian carcinoma.

目的: 探討尿激酶型纖溶酶原激活因子 ( UPA ) 的蛋白表達與上皮性卵巢癌生物學行為的關系.

互聯網

Thrombolytic therapy of acute MVT with Urokinase and Batroxobin is feasible, effective and safe.

尿激酶聯合巴曲酶治療MVT是有效和安全的.

互聯網